Matthew Campbell

FutureNeuro Principal Investigator wins prestigious European Research Council award

FutureNeuro Principal Investigator wins prestigious European Research Council awardFutureNeuro Principal Investigator, Dr. Matthew Campbell, Assistant Professor in the School of Genetics and Microbiology at Trinity College Dublin has won a prestigious European Research Council (ERC) Consolidator Grant award, valued at €2 million.His project, Retina Rhythm: Investigating the role of the inner retina in age-related macular degeneration…

BESTS Logo

FutureNeuro led research project funded by the Disruptive Technology Innovation Fund

FutureNeuro led research project funded by the Disruptive Technology Innovation FundThe project will see Singularity Alpha, Microsoft Ireland and Ergo partner with FutureNeuro researchers to better recruit patients for clinical trials.FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases hosted at RCSI, together with Singularity Alpha, Microsoft Ireland and Ergo have been successful…

Cell explorers logo

FutureNeuro joins Cell EXPLORERS

FutureNeuro joins Cell EXPLORERS to deliver Fantastic DNA workshops in Dublin areaWe are delighted to announce that we are now members of the Science Foundation Ireland Discover Funded Cell EXPLORERS national network!Cell Explorers is a science education and outreach programme. It started in the National University of Ireland, Galway in 2012 and has since expanded…

Researchers connect Irish and Scottish genetic maps

Researchers connect Irish and Scottish genetic maps Study led by RCSI and University of Edinburgh researchers identifies regions with highest Norse Viking ancestry in Scotland and links ancient Icelanders to the Irish and Scottish gene poolA study led by experts in human genetics at RCSI (Royal College of Surgeons in Ireland) and the University of…

JAMA Neurology

Tackling epilepsy with high-definition precision medicine: a review

Tackling epilepsy with high-definition precision medicine: a reviewDr. Hugh KearneyWe have recently published a review article in JAMA Neurology suggesting an exciting new direction using ‘high-definition’ precision medicine in the treatment of epilepsy.Precision medicine is the practice of tailoring healthcare to each person, rather than simply treating the disease. Until now, the focus of precision…

FutureNeuro partners with S3 Connected Health to develop new digital therapy management and patient support solutions

FutureNeuro partners with S3 Connected Health to develop new digital therapy management and patient support solutionsNew partnership will enable people with epilepsy to co-design solutions for managing their conditionA partnership, co-designing new healthcare technology solutions with people who have epilepsy has just been announced between FutureNeuro, the Science Foundation Ireland (SFI) Research Centre for Chronic…

FutureNeuro researchers integrate genomics data in to Irish electronic patient records

FutureNeuro researchers integrate genomics data in to Irish electronic patient records Improved access to genomic data empowers clinical teams to understand the causes of a person’s epilepsy and develop personalised careResearchers from the HSE Epilepsy Lighthouse Project and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases hosted by RCSI, have developed a…

LGBTSTEM Day

LGBTSTEM DayDiverse problems need diverse people and here in FutureNeuro, we’ve got both! Research shows that LGBTQ+ people in science, technology, engineering, and maths (STEM) continue to struggle to openly be themselves. We want to be part of the generation that changes that. July 5th is the International Day of LGBTQ+ People in Science, Technology, Engineering,…

Image of Jochen Prehn

FutureNeuro Principal Investigator to lead €7 million Parkinson’s research project

Professor Jochen Prehn, FutureNeuro Principal Investigator is co-ordinating a new research study which aims to deepen the understanding of Parkinson’s so that better treatments can be developed in the future. The project has been awarded €7m by the Innovative Medicines Initiative (IMI) with pharmaceutical industry and patient advocacy partners.The PD-MitoQUANT project aims to increase understanding…